Clearstead Advisors, LLC Gilead Sciences, Inc. Transaction History

Clearstead Advisors, LLC

$5.78 Billion
Q2 2024

A detailed history of Clearstead Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 3,207 shares of GILD stock, worth $282,472. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,207

Previous 3,202 0.16%

Holding current value

$282,472

Previous $234,000 5.98%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$63.15 - $72.88 $315 - $364	5 Added 0.16%	3,207 $220,000
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $4,080 - $4,975	-57 Reduced 1.75%	3,202 $234,000
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $1,465 - $1,661	-20 Reduced 0.61%	3,259 $264,000
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $2,661 - $2,904	-36 Reduced 1.09%	3,279 $245,000
Q3 2023 Nov 07, 2023	BUY	$73.94 - $80.67 $39,705 - $43,319	537 Added 19.33%	3,315 $248,000
Q2 2023 Aug 07, 2023	SELL	$76.01 - $86.7 $7,677 - $8,756	-101 Reduced 3.51%	2,778 $214,000
Q1 2023 May 09, 2023	BUY	$77.31 - $88.08 $36,799 - $41,926	476 Added 19.81%	2,879 $238,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $23,307 - $33,461	-374 Reduced 13.47%	2,403 $206,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $28,995 - $33,120	487 Added 21.27%	2,777 $171,000
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $7,792 - $8,776	135 Added 6.26%	2,290 $142,000
Q1 2022 May 04, 2022	BUY	$57.92 - $72.58 $62,843 - $78,749	1,085 Added 101.4%	2,155 $128,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $361,770 - $410,616	-5,576 Reduced 83.9%	1,070 $78,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $13,267 - $14,313	196 Added 3.04%	6,646 $464,000
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $8,314 - $9,084	131 Added 2.07%	6,450 $444,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $24,360 - $27,794	-406 Reduced 6.04%	6,319 $408,000
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $29,797 - $33,953	526 Added 8.49%	6,725 $392,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $19,375 - $24,360	-312 Reduced 4.79%	6,199 $392,000
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $407,346 - $473,004	5,631 Added 639.89%	6,511 $501,000
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $55,114 - $70,593	880 New	880 $66,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Account

Clearstead Advisors, LLC Gilead Sciences, Inc. Transaction History